Erlonat 150 Mg Tablet
In stock
Description
Erlonat 150 mg tablet contains Erlotinib, a potent tyrosine kinase inhibitor used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer. It works by inhibiting the Epidermal Growth Factor Receptor (EGFR) protein, stopping cancer cell growth, and is taken once daily on an empty stomach (1 hour before or 2 hours after meals).
Specifications
| Strength | 150 mg |
|---|---|
| Storage | Below 30°C, keep in a cool, dry place |
| Composition | Erlotinib Hydrochloride |
| Pack Size | Typically 30 tablets per bottle/strip |
| Administration | Oral (empty stomach) |
